Home › Markets › Health Care › KMTS

Kestra Medical Technologies Ltd. (KMTS)

KMTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$26.97
+0.22% on the day
Market cap
$1.6B
Small cap
Revenue · 2025
$95.1M
+59.0% on 2024
Net income · 2025
-$131.6M
-138.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerKMTS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2025
SEC CIK0001877184
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inD0

Financials · 2025

LineValue
Revenue$95.1M
Net income-$131.6M
Operating income-$134.7M
Net margin-138.4%
Operating margin-141.6%
Revenue growth+59.0%
Cash$291.3M
Total assets$379.3M
P/E (computed)Net income was not positive
P/S (computed)16.9×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-04-01
Latest annual report10-K2026-07-14
Latest quarterly / interim10-Q2026-09-14
Latest current report8-K2026-09-14
Latest proxyDEFA14A2026-07-28

Source: SEC EDGAR submissions feed, 175 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.4%
1 month+1.7%
3 months+6.8%
Year to date-3.5%
1 year+13.4%
From 52-week high-10.0%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
NVCRNovoCure Limited$14.30-2.85%$1.7B
ATECAlphatec Holdings Inc.$10.82-3.82%$1.7B
XRAYDENTSPLY SIRONA Inc.$8.51-0.29%$1.7B
LMATLeMaitre Vascular Inc.$81.55-1.64%$1.9B
INSPInspire Medical Systems Inc.$68.86-3.68%$2.0B
DRTSAlpha Tau Medical Ltd.$13.74-3.65%$1.3B
TNDMTandem Diabetes Care Inc.$16.65+1.22%$1.2B
IRMDiRadimed Corporation$89.65+0.20%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier